Morgan Stanley Maintains Equal-Weight on Exelon, Lowers Price Target to $49
Morgan Stanley analyst David Arcaro maintains Exelon (NASDAQ:EXC) with a Equal-Weight and lowers the price target from $50 to $49.
Share
Why It Matters
A big bank analyst thinks Exelon stock is neither especially good nor bad. They lowered their expected price slightly, which suggests they see small bumps ahead.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.